Loading…
Drug Target Review is a publication that provides news, analysis, and expert commentary on early-stage drug discovery. It covers topics such as antimicrobial resistance, oncology innovation, rare disease research, and the use of AI and computational tools in drug development.
AI named Drug Target Review from December 2025 to June 2026.
AI named Drug Target Review alongside Deep Genomics, ESM Metagenomic Atlas, and Genentech.
AI cited drugtargetreview.com in these answers, after aidegreeguide.com, businessmodelcanvastemplate.com, and codeocean.com.
drugtargetreview.com 5%Other sites 95%